FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joseph Frolkis

Research Profile

Concepts & Ideas

Disorders

Chemicals & Drugs

Activities & Behaviors

Patient Compliance

Living Beings

Geographic Areas

United States

Procedures

Co-author Network

Publications

TOP 3
David Litaker; Siran M Koroukian; Joseph P Frolkis; David C Aron
Disparities among the disadvantaged: variation in lipid management in the Ohio Medicaid program.
David Litaker; Susan A Flocke; Joseph P Frolkis; Kurt C Stange
Physicians' attitudes and preventive care delivery: insights from the DOPC study.
Joseph P Frolkis; Gregory Pearce; Dennis L Sprecher
Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joseph Frolkis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: David Litaker; Siran M Koroukian; Joseph P Frolkis; David C Aron
Disparities among the disadvantaged: variation in lipid management in the Ohio Medicaid program.
Preventive medicine 2006;42(4):313-5.
2005: David Litaker; Susan A Flocke; Joseph P Frolkis; Kurt C Stange
Physicians' attitudes and preventive care delivery: insights from the DOPC study.
Preventive medicine 2005;40(5):556-63.
2004: Joseph P Frolkis; Gregory Pearce; Dennis L Sprecher
Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins.
The American journal of cardiology 2004;94(10):1310-2.
2002: Joseph P Frolkis; Gregory Pearce; Vijay Nambi; Stephen Minor; Dennis L Sprecher
Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice.
The American journal of medicine 2002;113(8):625-9.
2002: Joseph P Frolkis; Gregory Pearce; Dennis L Sprecher
Implications of 2001 cholesterol treatment guidelines based on a retrospective analysis of a high-risk patient cohort.
The American journal of cardiology 2002;89(6):765-6.
2002: Byron J Hoogwerf; Dennis L Sprecher; Gregory Pearce; Monica Acevedo; Joseph P Frolkis; JoAnne M Foody; Jean A Cross; Fredric J Pashkow; Killian Robinson; Donald G Vidt
Blood glucose concentrations < or = 125 mg/dl and coronary heart disease risk.
The American journal of cardiology 2002;89(5):596-9.
2001: Jackson T Wright; William Cushman; Barry R Davis; Joshua I Barzilay; Pedro J Colon; D Egan; T Lucente; Chuke Nwachuku; Sara Pressel; Frans Leenen; Joseph P Frolkis; R Letterer; S Walsh; Jonathan Tobin; G E Deger
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience.
Controlled clinical trials 2001;22(6):659-73.
2001: Dennis L Sprecher; Joseph P Frolkis
Using the new cholesterol guidelines in everyday practice.
Cleveland Clinic journal of medicine 2001;68(7):617-22.
2000: Joseph P Frolkis; Gordon G Blackburn; Gregory Pearce; Dennis L Sprecher
Usefulness of providing physicians the results of risk factor assessments and treatment recommendations at discharge after coronary artery bypass grafting.
The American journal of cardiology 2000;86(4):455-7.
1999: Joseph P Frolkis
Screening for cardiovascular disease. Concepts, conflicts, and consensus.
The Medical clinics of North America 1999;83(6):1339-73.
1999: Joseph P Frolkis
Should one routinely screen for lipoprotein(a)?
Cleveland Clinic journal of medicine 1999;66(8):465-8.